Pharsight

Drugs that contain Ibandronate Sodium

1. Boniva patents expiration

BONIVA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7192938 HOFFMANN LA ROCHE Method of treatment using bisphosphonic acid
May, 2023

(9 months ago)

US7718634 HOFFMANN LA ROCHE Method of treatment using bisphosphonic acid
May, 2023

(9 months ago)

US7410957 HOFFMANN LA ROCHE Method of treatment using bisphosphonic acid
May, 2023

(9 months ago)

Market Authorisation Date: 16 May, 2003

Treatment: Treatment and prevention of osteoporosis in postmenopausal women by once-monthly oral administration of ibandronate sodium monohydrate equivalent to 150mg of ibandronic acid; Treatment and prevention ...

Dosage: TABLET;ORAL

How can I launch a generic of BONIVA before it's drug patent expiration?
More Information on Dosage

BONIVA family patents

Family Patents